Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Katzenstein

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|July 9, 2013
Dose-intensive cisplatin for hepatoblastoma: have you heard?Muna Qayed, Howard M Katzenstein
Pediatric Transplantation|June 28, 2017
Heart transplantation for anthracycline cardiomyopathy: Pump up the volumeRustin Meister, Howard M Katzenstein
Pediatric Blood & Cancer|March 21, 2009
Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulinTanya Watt, Barry Warshaw, Howard M Katzenstein
Current Problems in Cancer|February 23, 2010
NeuroblastomaNatia Esiashvili, Cynthia Anderson, Howard M Katzenstein
Pediatric Blood & Cancer|June 1, 2012
Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategiesAngela D Trobaugh-Lotrario, Howard M Katzenstein
Journal of Pediatric Hematology/Oncology|November 8, 2016
Prolonged Isotretinoin in Ultra High-Risk NeuroblastomaThomas Cash, Adina Alazraki, Muna Qayed, et al.
Clinics in Perinatology|February 15, 2021
Neonatal Liver TumorsHoward M Katzenstein, Allison Aguado, Bradley Cheek, et al.
The Oncologist|May 30, 2003
Advances in the diagnosis and treatment of neuroblastomaJoanna L Weinstein, Howard M Katzenstein, Susan L Cohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Predictive value of staging systems in hepatoblastomaRebecka L Meyers, Howard M Katzenstein, Marcio H Malogolowkin
Pediatric Transplantation|October 12, 2016
Cause and effect: the etiology of pediatric hepatocellular carcinoma and the role for liver transplantationAllison F O'Neill, Douglas W Hanto, Howard M Katzenstein
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|July 9, 2013
Dose-intensive cisplatin for hepatoblastoma: have you heard?Muna Qayed, Howard M Katzenstein
Pediatric Transplantation|June 28, 2017
Heart transplantation for anthracycline cardiomyopathy: Pump up the volumeRustin Meister, Howard M Katzenstein
Pediatric Blood & Cancer|March 21, 2009
Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulinTanya Watt, Barry Warshaw, Howard M Katzenstein
Current Problems in Cancer|February 23, 2010
NeuroblastomaNatia Esiashvili, Cynthia Anderson, Howard M Katzenstein
Pediatric Blood & Cancer|June 1, 2012
Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategiesAngela D Trobaugh-Lotrario, Howard M Katzenstein
Journal of Pediatric Hematology/Oncology|November 8, 2016
Prolonged Isotretinoin in Ultra High-Risk NeuroblastomaThomas Cash, Adina Alazraki, Muna Qayed, et al.
Clinics in Perinatology|February 15, 2021
Neonatal Liver TumorsHoward M Katzenstein, Allison Aguado, Bradley Cheek, et al.
The Oncologist|May 30, 2003
Advances in the diagnosis and treatment of neuroblastomaJoanna L Weinstein, Howard M Katzenstein, Susan L Cohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Predictive value of staging systems in hepatoblastomaRebecka L Meyers, Howard M Katzenstein, Marcio H Malogolowkin
Pediatric Transplantation|October 12, 2016
Cause and effect: the etiology of pediatric hepatocellular carcinoma and the role for liver transplantationAllison F O'Neill, Douglas W Hanto, Howard M Katzenstein
Pageof 8